Dyne Therapeutics, Inc. (DYN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -144.92M | -111.83M | -90.78M | -94.7M | -105.89M | -84.33M | -74.63M | -54.87M | -78.54M | -35.01M | -50.6M | -55.64M | -46.91M | -29.19M | -42.8M | -30.91M | -50.74M | -28.07M | -26.95M | -46.15M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -36.86% | -32.6% | -21.64% | -72.6% | -34.83% | -140.92% | -47.48% | 1.39% | -67.43% | -19.92% | -18.22% | -80.02% | 7.55% | -4% | -58.82% | 33.02% | -175.86% | -40.09% | -127% | -531.24% |
| Net Income | -120.85M | -111.95M | -108.04M | -110.86M | -115.36M | -89.54M | -97.13M | -65.1M | -65.65M | -66.64M | -60.21M | -64.9M | -44.19M | -38.83M | -41.38M | -52.3M | -35.58M | -51.79M | -42.58M | -29.95M |
| Depreciation & Amortization | 550K | 521K | 500K | 503K | 502K | 1.02M | 438K | 400K | 386K | 567K | 431K | 431K | 412K | 401K | 397K | 1.64M | 1.47M | 341K | 260K | 241K |
| Stock-Based Compensation | 13.08M | 11.23M | 0 | 10.52M | 13.02M | 0 | 8.74M | 6.74M | 19.91M | 5.73M | 4.88M | 4.75M | 4.62M | 3.83M | 3.83M | 0 | 0 | 0 | 3.64M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 727K | -365K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -76K | -313K | 10.89M | -512K | -452K | 9.27M | -866K | -1.15M | -352K | -921K | 166K | -119K | 171K | 246K | -489K | 3.39M | 5.12M | 6.04M | 684K | 4.89M |
| Working Capital Changes | -37.62M | -11.31M | 5.87M | 5.64M | -3.6M | -5.08M | 14.18M | 4.24M | -32.83M | 25.53M | 4.5M | 4.2M | -7.92M | 5.16M | -5.16M | 16.36M | -21.75M | 17.34M | 11.05M | -21.33M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -4.8M | -9.46M | 18.47M | 7.84M | -8.6M | -991K | 13.41M | 7.38M | -28.76M | 21.41M | 9.46M | -1.37M | -6.53M | 4.65M | -1.16M | 1.54M | -6.27M | 6.03M | 4.83M | 973K |
| Cash from Investing | -2.39M | 982K | -37.97M | 6.77M | 1.46M | -16.01M | -19.4M | 11.17M | -179.84M | 26.2M | 12.82M | 17.23M | 27.06M | 19.24M | 51.66M | 18.44M | -2.14M | -235K | -2.85M | -6.43M |
| Capital Expenditures | -221K | -484K | -19.18M | -60K | -981K | -1.07M | -253K | -857K | -191K | -82K | -167K | -250K | -230K | -519K | -886K | -261K | -1.4M | -1.99M | -881K | -738K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.47K | -12.99K | 0 | 23K | 34K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 30K | 10K | 0 | 14K | 0 | 0 | 0 | 0 | 0 | -30.47K | 12.99K | 0 | -23K | -34K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 7.06M | 430.96M | 217.33M | 100.77M | 141.24M | 3.64M | 18.01M | 379.86M | 408.39M | 147K | 454K | 24.91M | 28.82M | 37.2M | 70K | 99K | 18K | 89K | 457K | 25K |
| Debt Issued (Net) | 6.21M | 49.45M | -549K | 98.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 887K | 381.52M | 217.88M | 1.97M | 140.65M | 3.64M | 18.01M | 375.58M | 397.47M | -1K | 454K | 24.14M | 28.23M | 36.86M | 70K | 99K | 18K | 89K | 457K | 25K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -30K | 0 | 0 | 0 | 588K | 0 | 0 | 4.28M | 10.92M | 148K | 0 | 764K | 587K | 342K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -140.25M | 320.12M | 88.57M | 12.85M | 36.81M | -96.71M | -76.02M | 336.16M | 150.01M | -8.65M | -37.33M | -13.5M | 8.97M | 27.25M | 8.92M | -11.98M | -52.86M | -28.22M | -29.34M | -52.56M |
| Free Cash Flow | -145.14M | -112.32M | -109.96M | -94.76M | -106.87M | -85.41M | -74.88M | -55.73M | -78.73M | -35.09M | -50.77M | -55.89M | -47.14M | -29.71M | -43.69M | -31.17M | -52.14M | -30.06M | -27.83M | -46.89M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -35.81% | -31.5% | -46.85% | -70.05% | -35.75% | -143.42% | -47.5% | 0.3% | -67.02% | -18.1% | -16.2% | -79.31% | 9.59% | 1.15% | -56.98% | 33.52% | -183.34% | -44.8% | -131.38% | -535.17% |
| FCF per Share | -0.88 | -0.87 | -0.78 | -0.83 | -0.97 | -0.84 | -0.74 | -0.60 | -0.97 | -0.57 | -0.83 | -0.93 | -0.84 | -0.57 | -0.84 | -0.60 | -1.01 | -0.58 | -0.54 | -0.92 |
| FCF Conversion (FCF/Net Income) | 1.20x | 1.00x | 0.84x | 0.85x | 0.92x | 0.94x | 0.77x | 0.84x | 1.20x | 0.53x | 0.84x | 0.86x | 1.06x | 0.75x | 1.03x | 0.59x | 1.43x | 0.54x | 0.63x | 1.54x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |